Nucleic Acids Research, 2002, Vol. 30, No. 20 4470-4480
© 2002 Oxford University Press
Minimum length requirement of the alignment domain of human telomerase RNA to sustain catalytic activity in vitro
University Chemical Laboratory, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK
*To whom correspondence should be addressed. Tel: +44 1223 336347; Fax: +44 1223 336913; Email: sb10031{at}cam.ac.uk
Telomeres are essential for genomic stability and cell viability. Telomerase, the enzyme responsible for telomere maintenance, is composed of a reverse transcriptase protein subunit and an integral RNA component which contains the templating domain. In human telomerase, the template region consists of 11 nt (3'-rCAAUCCCAAUC-5') and comprises an alignment domain (italicised) plus a template sequence encoding the telomeric repeat d(GGT TAG). In this study, the alignment domain of human telomerase was systematically reduced from the 3' end and the resultant recombinant enzyme activity was evaluated in vitro. Deletion or substitution of one or two residues from the 3' end of the alignment domain caused only a slight reduction in overall catalytic activity and did not alter the processivity of the enzyme. Deletion or substitution of three or more residues from the 3' end of the alignment domain resulted in total loss of catalytic activity. These results suggest that the two most 3' terminal RNA residues are relevant but not essential for overall activity and that the minimal length requirement of the alignment domain is 3 nt. Furthermore, base pairing between the 3' end of the primer substrate and the first two residues of the alignment domain is also not an absolute requirement for processive synthesis.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Marrone, P. Sokhal, A. Walne, R. Beswick, M. Kirwan, S. Killick, M. Williams, J. Marsh, T. Vulliamy, and I. Dokal Functional characterization of novel telomerase RNA (TERC) mutations in patients with diverse clinical and pathological presentations Haematologica, August 1, 2007; 92(8): 1013 - 1020. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. C. Drosopoulos, R. DiRenzo, and V. R. Prasad Human Telomerase RNA Template Sequence Is a Determinant of Telomere Repeat Extension Rate J. Biol. Chem., September 23, 2005; 280(38): 32801 - 32810. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. McHugh, L. S. Gawron, S.-I. Matsui, and T. A. Beerman The Antitumor Enediyne C-1027 Alters Cell Cycle Progression and Induces Chromosomal Aberrations and Telomere Dysfunction Cancer Res., June 15, 2005; 65(12): 5344 - 5351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Rivera and E. H. Blackburn Processive Utilization of the Human Telomerase Template: LACK OF A REQUIREMENT FOR TEMPLATE SWITCHING J. Biol. Chem., December 17, 2004; 279(51): 53770 - 53781. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. Moriarty, D. T. Marie-Egyptienne, and C. Autexier Functional Organization of Repeat Addition Processivity and DNA Synthesis Determinants in the Human Telomerase Multimer Mol. Cell. Biol., May 1, 2004; 24(9): 3720 - 3733. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. T. UEDA and R. W. ROBERTS Analysis of a long-range interaction between conserved domains of human telomerase RNA RNA, January 1, 2004; 10(1): 139 - 147. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Ren, G. Gavory, H. Li, L. Ying, D. Klenerman, and S. Balasubramanian Identification of a new RNA{middle dot}RNA interaction site for human telomerase RNA (hTR): structural implications for hTR accumulation and a dyskeratosis congenita point mutation Nucleic Acids Res., November 15, 2003; 31(22): 6509 - 6515. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Huard, T. J. Moriarty, and C. Autexier The C terminus of the human telomerase reverse transcriptase is a determinant of enzyme processivity Nucleic Acids Res., July 15, 2003; 31(14): 4059 - 4070. [Abstract] [Full Text] [PDF]
|
|